Abstract
BACKGROUND: In a recent, prospective, double-blind, randomized, IVF trial (Engage), subjects in the reference group were treated with a standardized rFSH/GnRH antagonist protocol. The North American (NA) cohort made up 54% of these subjects, providing an opportunity to study the impact of patient demographics and clinical characteristics on clinical outcome with this simplified treatment regimen.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
